Efficient Gene Editing in Monogenic Diseases
André Choulika, PhD, chief executive officer and cofounder, Cellectis, discussed the company’s expansion into gene therapies.
Collaborating to Develop Oncologic Cell Therapies
André Choulika, PhD, chief executive officer and cofounder, Cellectis, discussed the company’s partnerships and science.
CAR T Therapies for Hematologic Malignancies and Solid Tumors
André Choulika, PhD, chief executive officer and cofounder, Cellectis, discussed therapies the company is developing.